SEC 13F Intelligence

Mpm Bioimpact LLC / TARS

Mpm Bioimpact LLC’s Tarsus Pharmaceuticals Inc Position

Does Mpm Bioimpact LLC own Tarsus Pharmaceuticals Inc (TARS)? Yes — 329.8K shares worth $23M (+1.79% of its 13F portfolio) as of Q1 2026, up from 328.9K shares the prior filed quarter.

Position Value
$23M
Q1 2026
Shares
329.8K
% of Portfolio
+1.79%
Quarters Held
4
currently held

Position History TARS

Reported value by quarter
Q2 ’25: $14MQ2 ’25Q3 ’25: $20MQ3 ’25Q4 ’25: $27MQ4 ’25Q1 ’26: $23MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026329.8K$23M+1.79%
Q4 2025328.9K$27M+3.08%
Q3 2025341.5K$20M+3.32%
Q2 2025341.5K$14M+2.40%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of TARS.